Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 36 Colonic Neoplasms 10 Rectal Neoplasms 8 Neoplasm Metastasis 8 Neoplasms 5 Pancreatic Neoplasms 2 Carcinoma, Neuroendocrine 2 Adenocarcinoma 2 Stomach Neoplasms 1 Ras-mutated Metastatic Colorectal Cancer 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Metastatic Pancreatic Ductal Adenocarcinoma 1 Metastatic Colorectal Adenocarcinoma 1 Liver Metastasis Colon Cancer 1 Gastrointestinal Neoplasms 1 Exanthema 1 Carcinoma, Basal Cell 1 Carcinoma 1 CRC 1 Advanced Cancer 1

Interventions

relatlimab 2 linrodostat 2 Nivolumab 2 Ipilimumab 2 Vorinostat 1 Trastuzumab 1 IFL protocol 1 Gemcitabine 1 Dasatinib 1 Cetuximab 1 BMS-813160 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Cancer × IFL protocol × Clear all

NCT05605509 2026-02-06

RP-6306 in Patients With Advanced Cancer

Canadian Cancer Trials Group

Phase 2 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡